AMPK in Intestinal Health and Disease: A Multifaceted Therapeutic Target for Metabolic and Inflammatory Disorders
Chamnan Yibcharoenporn,* Chatchai Muanprasat,* Aekkacha Moonwiriyakit, Saravut Satitsri, Nutthapoom Pathomthongtaweechai Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, 10540, Thailand*These authors contribut...
Saved in:
| Main Authors: | Yibcharoenporn C, Muanprasat C, Moonwiriyakit A, Satitsri S, Pathomthongtaweechai N |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ampk-in-intestinal-health-and-disease-a-multifaceted-therapeutic-targe-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Limosilactobacillus fermentum</i> MG4244 Protects Against Metabolic and Inflammatory Stress in <i>Caenorhabditis elegans</i>
by: Yebin Kim, et al.
Published: (2025-06-01) -
Long term ingestion of dietary ALEs induces metabolic disorders in mice by inducing gut dysbiosis and inhibiting AMPK/SIRT1 pathway
by: Yaya Wang, et al.
Published: (2025-02-01) -
Trends in intestinal aging: From underlying mechanisms to therapeutic strategies
by: Yajun Wang, et al.
Published: (2025-07-01) -
The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
by: Derek T Hall, et al.
Published: (2018-05-01) -
Targeting negative phosphorylation to activate AMPK
by: Alexia Pearah, et al.
Published: (2025-07-01)